Walusimbi 2013a

Study characteristics
Patient sampling	Cross‐sectional design, unknown manner of enrolment, prospective data collection
Patient characteristics and setting	Presenting signs and symptoms: cough for > 2 weeks, with or without fever, night sweats, loss of weight, or blood‐stained sputum, smear‐negative Age: adults, median 34 years (IQR 29 to 40) Sex, female: 56% HIV infection: 100% History of TB: not reported Sample size: 601 Clinical setting: inpatient and outpatient Laboratory level: central Country: Uganda World Bank Income Classification: low income High TB burden country: no High MDR‐TB burden country: no High TB/HIV burden country: yes Prevalence of TB cases in the study: 11.7%
Index tests	Index: Xpert MTB/RIF
Target condition and reference standard(s)	Target condition: pulmonary TB Reference standard for pulmonary TB: LJ and MGIT 960
Flow and timing
Comparative
Notes
Methodological quality
Item	Authors' judgement	Risk of bias	Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled?	Unclear
Was a case‐control design avoided?	Yes
Did the study avoid inappropriate exclusions?	No
		High	Low
DOMAIN 2: Index Test Xpert MTB/RIF
Were the index test results interpreted without knowledge of the results of the reference standard?	Yes
If a threshold was used, was it pre‐specified?	Yes
		Low	Low
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition?	Yes
Were the reference standard results for TB detection interpreted without knowledge of the results of the index test?	Yes
Were the reference standard results for rifampicin resistance detection interpreted without knowledge of the results of the index test?
		Low	Low
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard?	Yes
Did all patients receive the same reference standard?	Yes
Were all patients included in the analysis?	Yes
		Low